Market
Should investors be concerned about SYRE’s high price-to-sales ratio?
In the current trading session, Spyre Therapeutics Inc’s (SYRE) stock is trading at the price of $27.33, a fall of -4.67% over last night’s close.
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.